Literature DB >> 7862943

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

A F Arnsten1, J X Cai, B L Murphy, P S Goldman-Rakic.   

Abstract

Dopamine (DA) D1 receptor compounds were examined in monkeys for effects on the working memory functions of the prefrontal cortex and on the fine motor abilities of the primary motor cortex. The D1 antagonist, SCH23390, the partial D1 agonist, SKF38393, and the full D1 agonist, dihydrexidine, were characterized in young control monkeys, and in aged monkeys with naturally occurring catecholamine depletion. In addition, SKF38393 was tested in young monkeys experimentally depleted of catecholamines with chronic reserpine treatment. Injections of SCH23390 significantly impaired the memory performance of young control monkeys, but did not impair aged monkeys with presumed catecholamine depletion. Conversely, the partial agonist, SKF38393, improved the depleted monkeys (aged or reserpine-treated) but did not improve young control animals. The full agonist, dihydrexidine, did improve memory performance in young control monkeys as well as in a subset of aged monkeys. Consistent with D1 receptor mechanisms, agonist-induced improvements were blocked by SCH23390. Drug effects on memory performance occurred independently of effects on fine motor performance. These results underscore the importance of DA D1 mechanisms in cognitive function, and provide functional evidence of DA system degeneration in aged monkeys. Finally, high doses of D1 agonists impaired memory performance in aged monkeys, suggesting that excessive D1 stimulation may be deleterious to cognitive function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862943     DOI: 10.1007/bf02245056

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys.

Authors:  J R Taylor; M S Lawrence; D E Redmond; J D Elsworth; R H Roth; D E Nichols; R B Mailman
Journal:  Eur J Pharmacol       Date:  1991-07-09       Impact factor: 4.432

2.  Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.

Authors:  C Pifl; H Reither; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1991-09-17       Impact factor: 4.432

3.  D1 dopamine receptors in prefrontal cortex: involvement in working memory.

Authors:  T Sawaguchi; P S Goldman-Rakic
Journal:  Science       Date:  1991-02-22       Impact factor: 47.728

4.  The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

Authors:  A F Arnsten; J X Cai; P S Goldman-Rakic
Journal:  J Neurosci       Date:  1988-11       Impact factor: 6.167

5.  Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist.

Authors:  T W Lovenberg; W K Brewster; D M Mottola; R C Lee; R M Riggs; D E Nichols; M H Lewis; R B Mailman
Journal:  Eur J Pharmacol       Date:  1989-07-04       Impact factor: 4.432

6.  Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys.

Authors:  P S Goldman-Rakic; R M Brown
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

7.  Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey.

Authors:  P S Goldman; H E Rosvold
Journal:  Exp Neurol       Date:  1970-05       Impact factor: 5.330

8.  Aging in the rhesus monkey: effects on visual discrimination learning and reversal learning.

Authors:  R T Bartus; R L Dean; D L Fleming
Journal:  J Gerontol       Date:  1979-03

9.  Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.

Authors:  D M Mottola; W K Brewster; L L Cook; D E Nichols; R B Mailman
Journal:  J Pharmacol Exp Ther       Date:  1992-07       Impact factor: 4.030

10.  Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.

Authors:  V J Watts; C P Lawler; J H Gilmore; S B Southerland; D E Nichols; R B Mailman
Journal:  Eur J Pharmacol       Date:  1993-09-28       Impact factor: 4.432

View more
  157 in total

1.  A neurocomputational theory of the dopaminergic modulation of working memory functions.

Authors:  D Durstewitz; M Kelc; O Güntürkün
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  The physiological role of 5-HT2A receptors in working memory.

Authors:  Graham V Williams; Srinivas G Rao; Patricia S Goldman-Rakic
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

3.  Prefrontal dopamine D1 receptors and working memory in schizophrenia.

Authors:  Anissa Abi-Dargham; Osama Mawlawi; Ilise Lombardo; Roberto Gil; Diana Martinez; Yiyun Huang; Dah-Ren Hwang; John Keilp; Lisa Kochan; Ronald Van Heertum; Jack M Gorman; Marc Laruelle
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

4.  Hippocampal pyramidal cell disarray correlates negatively to cell number: implications for the pathogenesis of schizophrenia.

Authors:  S A Jönsson; A Luts; N Guldberg-Kjaer; A Brun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

5.  Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors.

Authors:  Yan-You Huang; Eleanor Simpson; Christoph Kellendonk; Eric R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

6.  Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex.

Authors:  Guojun Chen; Paul Greengard; Zhen Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

7.  Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists.

Authors:  Lisa A Bonner; Benjamin R Chemel; Val J Watts; David E Nichols
Journal:  Bioorg Med Chem       Date:  2010-07-27       Impact factor: 3.641

Review 8.  GPCR mediated regulation of synaptic transmission.

Authors:  Katherine M Betke; Christopher A Wells; Heidi E Hamm
Journal:  Prog Neurobiol       Date:  2012-01-28       Impact factor: 11.685

9.  Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation.

Authors:  Rouba Kozak; Tamás Kiss; Keith Dlugolenski; David E Johnson; Roxanne R Gorczyca; Kyle Kuszpit; Brian D Harvey; Polina Stolyar; Stacey J Sukoff Rizzo; William E Hoffmann; Dmitri Volfson; Mihaly Hajós; Jennifer E Davoren; Amanda L Abbott; Graham V Williams; Stacy A Castner; David L Gray
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

10.  Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.

Authors:  Deepak C D'Souza; Rajiv Radhakrishnan; Edward Perry; Savita Bhakta; Nagendra M Singh; Richa Yadav; Danielle Abi-Saab; Brian Pittman; Santosh K Chaturvedi; Mahendra P Sharma; Morris Bell; Chittaranjan Andrade
Journal:  Neuropsychopharmacology       Date:  2012-10-24       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.